{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:08:09Z","timestamp":1762542489349},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2016,1,28]],"date-time":"2016-01-28T00:00:00Z","timestamp":1453939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0146990","type":"journal-article","created":{"date-parts":[[2016,1,28]],"date-time":"2016-01-28T18:40:43Z","timestamp":1454006443000},"page":"e0146990","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["LDLR and PCSK9 Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA Carriers"],"prefix":"10.1371","volume":"11","author":[{"given":"Eguzkine","family":"Ochoa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikel","family":"Iriondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Manzano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asier","family":"Fullaondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irama","family":"Villar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Ruiz-Irastorza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M.","family":"Zubiaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andone","family":"Estonba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,1,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: understanding the antibodies","volume":"7","author":"PL Meroni","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"S Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(10)60709-X","article-title":"Antiphospholipid syndrome","volume":"376","author":"G Ruiz-Irastorza","year":"2010","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1177\/0961203306071004","article-title":"The environment and antiphospholipid syndrome","volume":"15","author":"Y Levy","year":"2006","journal-title":"Lupus"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.revmed.2008.05.020","article-title":"Antiphospholipid antibodies, antiphospholipid syndrome and viral infections","volume":"30","author":"D Sene","year":"2009","journal-title":"Rev Med Interne"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1741-7015-11-73","article-title":"How do autoimmune diseases cluster in families? A systematic review and meta-analysis","volume":"11","author":"J Cardenas-Roldan","year":"2013","journal-title":"BMC Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nrg1944","article-title":"Genetics of autoimmune diseases\u2014disorders of immune homeostasis","volume":"7","author":"PK Gregersen","year":"2006","journal-title":"Nat Rev Genet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/ATVBAHA.108.162545","article-title":"The epidemiology of venous thromboembolism in the community","volume":"28","author":"JA Heit","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"A299","DOI":"10.1016\/j.autrev.2009.11.013","article-title":"The geoepidemiology of the antiphospholipid antibody syndrome","volume":"9","author":"M Biggioggero","year":"2010","journal-title":"Autoimmun Rev"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/sj.gene.6364443","article-title":"Innate immune response gene expression profiles characterize primary antiphospholipid syndrome","volume":"9","author":"I Bernales","year":"2008","journal-title":"Genes Immun"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1055\/s-0037-1615676","article-title":"Plasma tumor necrosis factor alpha levels and the -238*A promoter polymorphism in patients with antiphospholipid syndrome","volume":"85","author":"ML Bertolaccini","year":"2001","journal-title":"Thromb Haemost"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.autrev.2011.12.006","article-title":"Val247Leu beta2-glycoprotein-I allelic variant is associated with antiphospholipid syndrome: systematic review and meta-analysis","volume":"11","author":"AJ Chamorro","year":"2012","journal-title":"Autoimmun Rev"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1046\/j.1365-2141.2000.01964.x","article-title":"The G1691 \u2014&gt; A mutation of factor V, but not the G20210 \u2014&gt; A mutation of factor II or the C677 \u2014&gt; T mutation of methylenetetrahydrofolate reductase genes, is associated with venous thrombosis in patients with lupus anticoagulants","volume":"108","author":"M Galli","year":"2000","journal-title":"Br J Haematol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1136\/ard.2006.063909","article-title":"Anti-beta2GPI-antibody-induced endothelial cell gene expression profiling reveals induction of novel pro-inflammatory genes potentially involved in primary antiphospholipid syndrome","volume":"66","author":"C Hamid","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/01.STR.31.6.1283","article-title":"Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children","volume":"31","author":"G Kenet","year":"2000","journal-title":"Stroke"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1002\/art.23756","article-title":"Proteomic analysis in monocytes of antiphospholipid syndrome patients: deregulation of proteins related to the development of thrombosis","volume":"58","author":"C Lopez-Pedrera","year":"2008","journal-title":"Arthritis Rheum"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1182\/blood-2005-07-2669","article-title":"Gene-expression patterns predict phenotypes of immune-mediated thrombosis","volume":"107","author":"A Potti","year":"2006","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1191\/0961203303lu402oa","article-title":"HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus","volume":"12","author":"GD Sebastiani","year":"2003","journal-title":"Lupus"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/03009740601089648","article-title":"Genotype Ser413\/Ser of PAI-2 polymorphism Ser413\/Cys is associated with anti-phospholipid syndrome and systemic lupus erythematosus in a familial case: comparison with healthy controls","volume":"36","author":"M Vazquez-Del Mercado","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11926-007-0031-0","article-title":"Mechanisms of aPL-mediated thrombosis: effects of aPL on endothelium and platelets","volume":"9","author":"ME Vega-Ostertag","year":"2007","journal-title":"Curr Rheumatol Rep"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/art.21549","article-title":"Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kappaB\/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1\/ERK pathway","volume":"54","author":"C Lopez-Pedrera","year":"2006","journal-title":"Arthritis Rheum"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/ncprheum0092","article-title":"Mechanisms of disease: atherosclerosis in autoimmune diseases","volume":"2","author":"Y Sherer","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/art.1780400322","article-title":"Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation","volume":"40","author":"N Del Papa","year":"1997","journal-title":"Arthritis Rheum"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2005-03-1319","article-title":"Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor","volume":"106","author":"F Fischetti","year":"2005","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.99.17.2227","article-title":"Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression","volume":"99","author":"J George","year":"1999","journal-title":"Circulation"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11926-009-0009-1","article-title":"Atherosclerosis in autoimmune diseases","volume":"11","author":"E Matsuura","year":"2009","journal-title":"Curr Rheumatol Rep"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"18602","DOI":"10.1074\/jbc.M702027200","article-title":"Binding of proprotein convertase subtilisin\/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation","volume":"282","author":"DW Zhang","year":"2007","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2008.03.009","article-title":"Variation in PCSK9, low LDL cholesterol, and risk of peripheral arterial disease","volume":"202","author":"AR Folsom","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e1043","DOI":"10.1371\/journal.pone.0001043","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9) gene is a risk factor of large-vessel atherosclerosis stroke","volume":"2","author":"S Abboud","year":"2007","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ejim.2003.08.010","article-title":"Low-dose interferon-alpha accelerates atherosclerosis in an LDL receptor-deficient mouse model","volume":"14","author":"Z Levy","year":"2003","journal-title":"Eur J Intern Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e2986","DOI":"10.1371\/journal.pone.0002986","article-title":"Lifelong reduction of LDL-cholesterol related to a common variant in the LDL-receptor gene decreases the risk of coronary artery disease\u2014a Mendelian Randomisation study","volume":"3","author":"P Linsel-Nitschke","year":"2008","journal-title":"PLoS One"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1182\/blood-2010-03-277079","article-title":"Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile","volume":"116","author":"N Martinelli","year":"2010","journal-title":"Blood"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1055\/s-0037-1616089","article-title":"Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations\u2014a cooperative project of the European Antiphospholipid Forum","volume":"86","author":"A Tincani","year":"2001","journal-title":"Thromb Haemost"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1191\/0961203302lu202cr","article-title":"Revisiting the anticardiolipin test and its standardization","volume":"11","author":"EN Harris","year":"2002","journal-title":"Lupus"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.thromres.2004.06.002","article-title":"Consensus guidelines for anticardiolipin antibody testing","volume":"114","author":"RC Wong","year":"2004","journal-title":"Thromb Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1055\/s-0038-1649901","article-title":"Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH","volume":"74","author":"JT Brandt","year":"1995","journal-title":"Thromb Haemost"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0049-3848(02)00400-0","article-title":"Laboratory diagnosis of the antiphospholipid syndrome","volume":"108","author":"F Wisl\u00f8ff","year":"2002","journal-title":"Thromb Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"JC Barrett","year":"2005","journal-title":"Bioinformatics"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"S Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"key":"ref40","first-page":"12","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"YBY Hochberg","year":"1995","journal-title":"Journal of the Royal Statistical Society Series B (Methodological)"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1093\/nar\/30.9.e36","article-title":"Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR","volume":"30","author":"MW Pfaffl","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1101\/gr.137323.112","article-title":"Annotation of functional variation in personal genomes using RegulomeDB","volume":"22","author":"AP Boyle","year":"2012","journal-title":"Genome Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/ng.2756","article-title":"Systematic identification of trans eQTLs as putative drivers of known disease associations","volume":"45","author":"HJ Westra","year":"2013","journal-title":"Nat Genet"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1073\/pnas.76.7.3330","article-title":"Receptor-mediated endocytosis: insights from the lipoprotein receptor system","volume":"76","author":"MS Brown","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/humu.1380010602","article-title":"Molecular genetics of the LDL receptor gene in familial hypercholesterolemia","volume":"1","author":"HH Hobbs","year":"1992","journal-title":"Hum Mutat"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev.ge.13.120179.001355","article-title":"The LDL receptor locus and the genetics of familial hypercholesterolemia","volume":"13","author":"JL Goldstein","year":"1979","journal-title":"Annu Rev Genet"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.1073\/pnas.0602311103","article-title":"Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus","volume":"103","author":"AK Stanic","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1191\/0961203306lu2288oa","article-title":"Valine\/Leucine247 polymorphism of beta2-glycoprotein I in patients with antiphospholipid syndrome: lack of association with anti-beta2-glycoprotein I antibodies","volume":"15","author":"J Swadzba","year":"2006","journal-title":"Lupus"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/art.20741","article-title":"Significance of valine\/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant","volume":"52","author":"S Yasuda","year":"2005","journal-title":"Arthritis Rheum"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/ar2631","article-title":"The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus","volume":"11","author":"LE Full","year":"2009","journal-title":"Arthritis Res Ther"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0146990","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T10:50:14Z","timestamp":1589021414000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0146990"}},"subtitle":[],"editor":[{"given":"Esteban","family":"G\u00e1ndara","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,1,28]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0146990","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,28]]}}}